APACI - Asia-Pacific Alliance for the Control of Influenza
APACI is a Hong Kong–registered, Melbourne-operated charitable alliance that, since 2002, has convened Asia-Pacific clinicians, virologists, and health ministries to reduce the burden of influenza and respiratory diseases through publications, webinars, regional workshops, and the World Influenza Conference series.
- Company typePrivate
- Founded2002
- HeadquartersHong Kong, China
- Headcount1–10
- GTM typeB2B
- OfferingServices
What APACI - Asia-Pacific Alliance for the Control of Influenza does
APACI - Asia-Pacific Alliance for the Control of Influenza is a Hong Kong–registered charitable institution (company limited by guarantee) with an operational office in Melbourne, founded in 2002 and operating with a five-person core team. It functions as a member-driven, regional convening body for influenza and respiratory disease control, serving clinicians, virologists, epidemiologists, government health ministries, and frontline healthcare workers across at least 15 Asia-Pacific markets. Its mission is to reduce the burden of influenza and other respiratory diseases through knowledge dissemination and policy advocacy, with WHO and country-level CDC partners as collaborators rather than customers.
Its core outputs are a portfolio of publications (APACI Newsletter, APACI Media Bulletin, APACI Information Sheets, Influenza – Asian Focus), an Influenza mobile information app, an ongoing webinar series (notably the Epidemiology and Policy Advocacy programme and the 2020 antiviral treatment series), and a recurring calendar of regional workshops and the flagship World Influenza Conference (held 2018, 2020, 2022, 2024, with the 5th edition scheduled for Chengdu in June 2026). Adjacent activities include country-specific influenza workshops in markets such as Thailand, Vietnam, Malaysia, India, China, and Korea. Underlying technology is conventional content, web and email infrastructure; there is no proprietary technical platform.
The revenue model is non-commercial: APACI operates through event sponsorships, grants, and in-kind support from pharmaceutical industry sponsors (Seqirus, Roche, IFPMA) and partner organisations (WHO, ESWI, NAIIS, isirv, country-level health bodies). Its primary customer segments are healthcare professionals and government health authorities in the Asia-Pacific region; it does not sell licences, products, or subscriptions as a for-profit entity would. Distribution is direct engagement via website, email subscription, social media, webinars, and in-person conferences across the region.
APACI - Asia-Pacific Alliance for the Control of Influenza firmographics
Firmographics- Name
- APACI - Asia-Pacific Alliance for the Control of Influenza
- Legal name
- Asia-Pacific Alliance for the Control of Influenza
- Website
- https://apaci.asia
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- APACI is a Hong Kong–registered, Melbourne-operated charitable alliance that, since 2002, has convened Asia-Pacific clinicians, virologists, and health ministries to reduce the burden of influenza and respiratory diseases through publications, webinars, regional workshops, and the World Influenza Conference series.
- Ownership category
- akta.pro rank
APACI - Asia-Pacific Alliance for the Control of Influenza industry classification
Industry- Product category
- Public Health Education
- NAICS
- Voluntary Health Organizations (813212)
- SIC
- Services-Membership Organizations (8600)
- akta.pro industry
- Humanitarian Health Coordination & Emergency Response PartnershipsHealthcare & Life Sciences/Public Health, Government & Regulators/Global Health Initiatives & PartnershipsAssociation & Society Conference Management (Nonprofit, Professional Bodies)Travel & Hospitality/MICE (Meetings, Incentives, Conferences & Exhibitions)/Professional Conference Organizers (PCOs) & Meeting Planners
Keywords
Where APACI - Asia-Pacific Alliance for the Control of Influenza is headquartered
LocationHeadquarters
- HQ city
- Hong Kong
- HQ country
- China
- HQ region
- Asia
Offices2 records
Markets served
APACI - Asia-Pacific Alliance for the Control of Influenza business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Revenue model
- Not applicable - charitable institution: APACI is a charitable institution (company limited by guarantee) that operates through sponsorships, grants, and membership support. The organization does not generate commercial revenue from products or services. Funding appears to come from pharmaceutical industry sponsors (such as Seqirus, Roche, IFPMA) and organizational partnerships for specific events and programs.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
APACI - Asia-Pacific Alliance for the Control of Influenza product offering
Product offeringCore offering
APACI is a charitable alliance that minimizes the impact of influenza and other respiratory diseases in the Asia-Pacific by producing educational publications, running webinars and workshops, and convening healthcare professionals, researchers, and government health authorities through annual meetings and conferences. Its deliverables include the APACI Newsletter, APACI Media Bulletin, APACI Information Sheets, the Influenza – Asian Focus publication, an Influenza App, and major convenings such as the World Influenza Conference.
Product overview
APACI is a charitable institution that operates as a membership-based alliance focused on minimizing the impact of influenza and other respiratory diseases in the Asia-Pacific region. The organization offers a portfolio of educational resources and publications including the APACI Newsletter, APACI Media Bulletin, APACI Information Sheets, and the Influenza – Asian Focus publication. APACI also hosts educational webinars and maintains an Influenza App. The organization facilitates annual meetings and conferences including the World Influenza Conference and regional workshops, sharing expertise and best practices via these platforms. APACI has been active since 2002 and operates under an independent Board of Directors with membership consisting of individuals with recognized expertise in influenza and respiratory illnesses.
Differentiator
Problem solved
Functional benefit
Products and services
- APACI Newsletter Regular newsletter publication keeping APACI members and colleagues in the respiratory disease field up to date with developments in the Asia-Pacific region. Targeted at healthcare professionals, researchers, and policymakers.
- APACI Media Bulletin Media bulletin providing timely updates on influenza-related news and developments across the Asia-Pacific region, distributed to healthcare professionals and the respiratory disease community.
- APACI Information Sheet A5 educational information sheets providing concise resources on influenza topics for healthcare professionals and the public.
- Influenza – Asian Focus Regional publication covering influenza-related topics specific to Asia, providing context-specific insights for the Asia-Pacific respiratory disease community.
- Influenza App Mobile application providing influenza-related information and resources for users in the Asia-Pacific region, supporting healthcare professionals and the public with on-the-go access to influenza content.
- Epidemiology and Policy Advocacy Webinar Series Educational webinar series bringing together speakers from across the Asia-Pacific region to discuss vaccine and anti-viral uptake for respiratory pathogens, targeted at healthcare professionals, researchers and policy advocates.
- APACI Conference Alerts and Annual Meetings Conferences, workshops and meetings programme (including the World Influenza Conference, Asia-Pacific Influenza Summits and regional workshops) bringing together healthcare professionals, researchers and policymakers across the Asia-Pacific region.
Quantifiable outcome
- Over 200 delegates from 31-33 countries attend major APACI summits, demonstrating strong regional reach
Companies that use APACI - Asia-Pacific Alliance for the Control of Influenza
Customer profileSegments3 records
Ideal customer profiles3 records
APACI - Asia-Pacific Alliance for the Control of Influenza technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
APACI - Asia-Pacific Alliance for the Control of Influenza partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered major, regional and core.
- ESWI (European Scientific Working group on Influenza)majorESWI collaborated with APACI to organize the 2018 World Influenza Conference in Beijing, marking the centenary of the 1918 influenza pandemic.
- NAIIS (National Adult and Influenza Immunization Summit)majorNAIIS collaborated with APACI to organize the 2018 World Influenza Conference in Beijing, focusing on preparing for the next pandemic.
- isirv (International Society for Influenza and other Respiratory Virus Diseases)majorisirv collaborated with APACI to organize the 2018 World Influenza Conference in Beijing.
- KIIT University (India)regionalAPACI collaborated with KIIT University in Odisha, India to hold the 2018 Influenza Workshop in Bhubaneswar.
- Influenza Foundation of India (IFI)regionalAPACI collaborated with the Influenza Foundation of India for the 2018 Workshop in Bhubaneswar.
- Association of Physicians of India (Odisha branch)regionalAPACI collaborated with the Association of Physicians of India (Odisha branch) for the 2018 Workshop in Bhubaneswar.
- Regional Medical Research Center (Indian Council of Medical Research)regionalAPACI collaborated with the Regional Medical Research Center (ICMR) for the 2018 Workshop in Bhubaneswar.
- Research Society for the Study of Diabetes in IndiaregionalAPACI collaborated with the Research Society for the Study of Diabetes in India for the 2018 Workshop in Bhubaneswar.
- Chinese Preventive Medicine Association (CPMA)coreAPACI worked with CPMA and China CDC to hold the 2017 Symposium on Seasonal Influenza Vaccination Policy Development and Implementation in Beijing, China.
- China CDC (China Center for Disease Control and Prevention)coreAPACI collaborated with China CDC for the 2017 Symposium on Seasonal Influenza Vaccination Policy Development and Implementation in Beijing, China.
- Malaysian Paediatric Association (MPA)regionalAPACI co-hosted the 2016 Influenza Workshop in Kuala Lumpur with MPA, along with MSIDC and OGSM.
- Malaysian Society of Infectious Diseases and Chemotherapy (MSIDC)regionalAPACI co-hosted the 2016 Influenza Workshop in Kuala Lumpur with MSIDC.
- Obstetrical and Gynaecological Society of Malaysia (OGSM)regionalAPACI co-hosted the 2016 Influenza Workshop in Kuala Lumpur with OGSM.
- Influenza Foundation of Thailand (IFT)coreThe Influenza Foundation of Thailand partnered with APACI for the inaugural 2012 1st Asia-Pacific Influenza Summit in Bangkok, providing organizational support and co-hosting the summit dinner.
- WHO (World Health Organization)coreAPACI works with WHO on pandemic preparedness, surveillance, and influenza control initiatives. WHO representatives participate in APACI meetings and conferences as speakers and advisors.
- Immunisation CoalitionregionalThe Immunisation Coalition conducts educational webinars for healthcare professionals on immunisations, and APACI shares information about these webinars on its Forthcoming Meetings page.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
APACI - Asia-Pacific Alliance for the Control of Influenza competitors and assessment
Company assessmentBroad incumbents
- CDC Foundation: The CDC Foundation is a US-based nonprofit that mobilizes philanthropic and private-sector resources to support CDC's public health mission. As a nonprofit model that aggregates sponsor funding around respiratory disease priorities, it is comparable in revenue/sponsor model to APACI.
- Task Force for Global Health: A large US-headquartered nonprofit that works on vaccine-preventable diseases, neglected tropical diseases and pandemic preparedness with major pharma/foundation funding. It is comparable to APACI as a globally active, sponsor-funded health coordination nonprofit.
- Sabin Vaccine Institute: An international nonprofit that advances vaccine knowledge and uptake through advocacy, research and education programs. Comparable to APACI as a vaccine-policy focused nonprofit operating across multiple geographies.
Emerging players
- ReSViNET (Respiratory Syncytial Virus Network): ReSViNET is an international nonprofit foundation dedicated to advancing knowledge on RSV and respiratory infections through research and education. It mirrors APACI's expansion from a single pathogen (RSV) to broader respiratory disease coordination.
Regional players
- Immunisation Coalition: An Australian health charity promoting immunisation awareness and education through webinars and resources for healthcare professionals. Like APACI it runs vaccination-focused educational webinars and is a listed resource partner on APACI's Forthcoming Meetings page.
- Infection Control Africa Network (ICAN): ICAN is a regional nonprofit that coordinates infection control expertise across Africa via workshops, networks and educational resources. It mirrors APACI's membership- and meeting-led model but for a different continent's disease-control community.
Direct peers
- isirv - International Society for Influenza and other Respiratory Virus Diseases: isirv is the leading international scientific society dedicated to influenza and respiratory virus diseases, organizing flagship conferences and publications. APACI and isirv jointly organized the 2018 World Influenza Conference and operate in the same respiratory-disease knowledge-sharing space.
- ESWI - European Scientific Working group on Influenza: ESWI is APACI's European counterpart — a multidisciplinary scientific working group that organizes the European Influenza Congress and similar knowledge-sharing activities. APACI and ESWI have co-organized the World Influenza Conference, making this the closest direct functional peer.
- NAIIS - National Adult and Influenza Immunization Summit: NAIIS is a US-focused action-oriented summit convening healthcare professionals and public health partners to boost adult influenza immunization. APACI and NAIIS co-organized the 2018 World Influenza Conference, making them structurally comparable convener platforms.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
APACI - Asia-Pacific Alliance for the Control of Influenza social profiles
Digital presenceAPACI - Asia-Pacific Alliance for the Control of Influenza financial estimates
Financial estimateRevenue estimate
Valuation estimate
APACI - Asia-Pacific Alliance for the Control of Influenza leadership team
Management profileNumber of profiles
Profiles4 records
APACI - Asia-Pacific Alliance for the Control of Influenza funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
APACI - Asia-Pacific Alliance for the Control of Influenza M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about APACI - Asia-Pacific Alliance for the Control of Influenza
What does APACI - Asia-Pacific Alliance for the Control of Influenza do?
APACI is a charitable alliance that minimizes the impact of influenza and other respiratory diseases in the Asia-Pacific by producing educational publications, running webinars and workshops, and convening healthcare professionals, researchers, and government health authorities through annual meetings and conferences. Its deliverables include the APACI Newsletter, APACI Media Bulletin, APACI Information Sheets, the Influenza – Asian Focus publication, an Influenza App, and major convenings such as the World Influenza Conference.
Is APACI - Asia-Pacific Alliance for the Control of Influenza a public or private company?
APACI - Asia-Pacific Alliance for the Control of Influenza is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was APACI - Asia-Pacific Alliance for the Control of Influenza founded?
APACI - Asia-Pacific Alliance for the Control of Influenza was founded in 2002. It employs 1 to 10 people.
Where is APACI - Asia-Pacific Alliance for the Control of Influenza based?
APACI - Asia-Pacific Alliance for the Control of Influenza is headquartered in Hong Kong, China, in the Asia region.
How does APACI - Asia-Pacific Alliance for the Control of Influenza make money?
One revenue line is on record: not applicable - charitable institution.
Who are APACI - Asia-Pacific Alliance for the Control of Influenza's main competitors?
Broad incumbents on record are CDC Foundation, Task Force for Global Health and Sabin Vaccine Institute. ReSViNET (Respiratory Syncytial Virus Network) is listed as an emerging player. Regional players are Immunisation Coalition and Infection Control Africa Network (ICAN). Direct peers are isirv - International Society for Influenza and other Respiratory Virus Diseases, ESWI - European Scientific Working group on Influenza and NAIIS - National Adult and Influenza Immunization Summit.
Does APACI - Asia-Pacific Alliance for the Control of Influenza have an API?
No public API is recorded for APACI - Asia-Pacific Alliance for the Control of Influenza.
What industry is APACI - Asia-Pacific Alliance for the Control of Influenza in?
APACI - Asia-Pacific Alliance for the Control of Influenza's product category is Public Health Education. Its primary akta.pro industry code is HLAJAOAI, Humanitarian Health Coordination & Emergency Response Partnerships, with a secondary code of THAHACAA, Association & Society Conference Management (Nonprofit, Professional Bodies). Its NAICS code is 813212 and its SIC code is 8600.